However, an article in 2003 demonstrated that CD44 and CD24 are viable cell surface markers for identifying breast cancer stem cells by in vivo xenograft formation of serially diluted xenograft tumor cells derived from multiple passaging in mice [3]. The gene discussed is CD24; the disease is breast carcinoma.